Discover
ANIK
Anika Therapeutics, Inc.
15.16
1 x 14.00
1 x 15.85
bid
ask
+
0.10
0.66%
1 @ 04:00 PM
15.13 -0.03 (0.20%)
| Ytd | 57.75% | |
| 1y | 41.81% |
14.98
day range
15.33
7.87
52 week range
16.49
| Open | 15.00 | Prev Close | 15.06 | Low | 14.98 | High | 15.33 | Mkt Cap | 201.71M |
| Vol | 42.44K | Avg Vol | 86.80K | EPS | 0.49 | P/E | 30.94 | Forward P/E | -81.65 |
| Beta | 0.23 | Short Ratio | 2.43 | Inst. Own | 91.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 14.97 | 200-d Avg | 12.25 | 1yr Est | 26.50 |
| Income Statement | |||
| Total Revenue | 29.61M | ||
| Revenues (USD) | 29.61M | ||
| Cost of Revenue | 10.62M | ||
| Gross Profit | 19.00M | ||
| Operating Expenses | 24.49M | ||
| Research and Development Expense | 6.71M | ||
| Selling, General and Administrative Expense | 17.77M | ||
| Operating Income | -5.49M | ||
| Income Tax Expense | 235.00K | ||
| Net Income | -5.06M | ||
| Net Income Common Stock | -5.06M | ||
| Net Income Common Stock (USD) | -5.06M | ||
| Consolidated Income | -5.06M | ||
| Earnings per Basic Share | -0.37 | ||
| Earnings per Basic Share (USD) | -0.37 | ||
| Earnings per Diluted Share | -0.37 | ||
| Earning Before Interest & Taxes (EBIT) | -4.82M | ||
| Earning Before Interest & Taxes (USD) | -4.82M | ||
| Weighted Average Shares | 13.53M | ||
| Weighted Average Shares Diluted | 13.53M | ||
| Balance Sheet | |||
| Cash and Equivalents | 41.02M | ||
| Cash and Equivalents (USD) | 41.02M | ||
| Investments | 5.68M | ||
| Investments Non-Current | 5.68M | ||
| Trade and Non-Trade Receivables | 25.77M | ||
| Current Assets | 93.56M | ||
| Property, Plant & Equipment Net | 65.15M | ||
| Total Assets | 179.39M | ||
| Total Debt | 23.79M | ||
| Current Liabilities | 20.97M | ||
| Debt Non-Current | 23.79M | ||
| Total Liabilities | 45.49M | ||
| Accumulated Retained Earnings (Deficit) | 55.73M | ||
| Accumulated Other Comprehensive Income | -5.31M | ||
| Shareholders Equity | 133.90M | ||
| Shareholders Equity (USD) | 133.90M | ||
| Assets Non-Current | 85.83M | ||
| Total Debt (USD) | 23.79M | ||
| Goodwill and Intangible Assets | 9.54M | ||
| Inventory | 22.84M | ||
| Liabilities Non-Current | 24.52M | ||
| Trade and Non-Trade Payables | 6.34M | ||
| Tax Assets | 1.15M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.87M | ||
| Net Cash Flow from Financing | -10.35M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -16.46M | ||
| Capital Expenditure | -1.43M | ||
| Issuance (Purchase) of Equity Shares | -8.69M | ||
| Net Cash Flow from Investing | -1.24M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 192.00K | ||
| Net Cash Flow from Operations | -4.85M | ||
| Effect of Exchange Rate Changes on Cash | -29.00K | ||
| Share Based Compensation | 6.64M | ||